Adenosine is a selective pulmonary vasodilator in cardiac surgical patients

Chest

Volumn 109, Issue 1, 1996, Pages 41-46

  Fullerton, David A ^a   Kirson, Lyle E ^a   Jones, Stephen D ^a   McIntyre Jr , Robert C ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

adenosine; cardiac surgery; PVR

Indexed keywords

ADENOSINE; ANESTHETIC AGENT;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SELECTIVITY; GENERAL ANESTHESIA; HEART SURGERY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

EID: 0030029297     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.1.41     Document Type: Article

References (29)

1. Packer M, Greenberg B, Massie B, et al. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med 1982; 306:1326-31
2. Kadowitz PJ, Hyman AL. Hydralazine and the treatment of primary pulmonary hypertension. N Engl J Med 1982; 306:1357-59
3. Fishman AP. Pulmonary circulation. In: Fishman AP, ed. Handbook of physiology: the respiratory system (Vol 1) Bethesda, Md: American Physiologic Society: 1985; 93-165
4. Fullerton DA, Hahn AR, Banerjee A, et al. Pulmonary vascular smooth muscle relaxation by cGMP-versus cAMP-mediated mechanisms. J Surg Res 1994; 57:259-63
5. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res 1980; 47:807-13
6. Forrester T. Harper AM, McKenzi ET, et al. Effect of adenosine triphosphate and some derivatives on cerebral blood flow and metabolism. J Physiol (London) 1989; 296:343-55
7. Klabunde RE. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 1983; 93:21-6
8. Mentzer RM Jr, Rubio R, Berne RM. Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol 1975; 229:1625-31
9. Neely CF, Kadowitz, PJ, Lippton H, et al. Adenosine does not mediate the pulmonary vasodilator response of adenosine 5′-triphosphate in the feline pulmonary vascular bed. J Pharmacol Exp Ther 1989; 250:170-76
10. Catravas JD. Removal of adenosine from the rabbit pulmonary circulation in vivo and in vitro. Circ Res 1984; 54:603-11
11. McCormack DG, Clarke B, Barnes PJ. Characterization of adenosine receptors in human pulmonary arteries. Am J Physiol 1989; 256:H41-46
12. Morris AH, Chapman RH, Gardner RN. Frequency of technical problems encountered in the measurement of pulmonary artery wedge pressure. Crit Care Med 1984; 12:164-70
13. Fullerton DA, Kirsen LE, St Cyr JA, et al. Influence of hydrogen ion concentration versus carbon dioxide tension on pulmonary vascular resistance following cardiac operation. J Thorac Cardiovasc Surg 1993; 106:528-36
14. Fullerton DA, Kirson LE, St Cyr JA, et al. The influence of respiratory acid-base status on adult pulmonary vascular resistance before and after cardiopulmonary bypass. Chest 1993; 93:1091-95
15. Edlund A, Sollevi A, Linde B. Haemodynamic and metabolic effects of infused adenosine in man. Clin Sci 1990; 79:131-38
16. Bush A, Busst CM, Clarke B, et al. Effect of infused adenosine on cardiac output and systemic resistance in normal subjects. Br J Clin Pharmacol 1989; 27:165-71
17. Fuller RW, Maxwell DL, Conradson T-BG, et al. Circulatory and respiratory effects of infused adenosine in conscious man. Br J Clin Pharmacol 1987; 92:789-94
18. Morgan JM, McCormack DG, Griffiths MJD, et al. Adenosine as a vasodilator in primary pulmonary hypertension. Circulation 1991; 84:1145-49
19. Öwall A, Gordon E, Lagerkranser M, et al. Clinical experience with adenosine for controlled hypotension during cerebral aneurysm surgery. Anesth Analg 1987; 66:229-34
20. Öwall A, Järnberg P-O, Brodin L-Å, et al. Effects of adenosine-induced hypotension on myocardial hemodyamics and metabolism in fentanyl anesthetized patients with peripheral vascular disease. Anesthesiology 1988; 68:426-31
21. Camara ML, Aris A, Alvarez J, et al. Hemodynamic effects of prostaglandin E1 and isoproterenol early alter cardiac operations for mitral stenosis. J Thorac Cardiovasc Surg 1992; 103:1177-85
22. Tinker JH. Dobutamine for inotropic support during emergence from cardiopulmonary bypass. Anesthesiology 1970; 44:281-88
23. F a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg 1985; 89:567-72
24. Girard C, Lehort JJ, Pannetier JC, et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77:880-83
25. Davis DA, Russo P. Successful treatment of acute postoperative pulmonary hypertension with nifedipine. Ann Thorac Surg 1992; 53:148-150
26. Deeb GM, Bolling SF, Guynn TP, et al. Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplantation. Ann Thorac Surg 1989; 48:665-69
27. Vlahakes GJ, Turley K, Hoffman JIE. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981; 63:87-95
28. Prewitt RM, Ghigone M. Treatment of right ventricular dysfunction in acute respiratory failure. Crit Care Med 1983; 11:346-52
29. Weigelt JA, Gewertz, BL, Aurbakken CM, et al. Pharmacologic alterations in pulmonary artery pressure in the adult respiratory distress syndrome. J Surg Res 1982; 32:243-48